Multidisciplinary Treatment of Chronic Vulvar Pain

Chronic Pain Clinical Trial

Official title: Multidisciplinary Treatment of Chronic Vulvar Pain - a Randomized Controlled Study

Status Recruiting

Clinical Trial Summary

Vulvodynia (i.e. chronic vulvar pain without identifiable cause) is a heterogeneous clinical entity with a complex multifactorial causation. It is long lasting and difficult to treat, and the general consensus of current guidelines states that patients with vulvodynia benefit from a compound multidisciplinary intervention targeting mucosal hypersensitivity, pelvic muscle floor dysfunction and general pain management. However, there is little empiric evidence to support this recommendation. This will be a randomized controlled trial comparing multidisciplinary treatment with standard care for women with vulvodynia.

Clinical Trial Description

Patients with chronic vulvar pain constitute a heterogeneous group with regards to causes and moderators of pain. Multidisciplinary teams simultaneously assess contributing factors such as infections and dermatoses and treat known mediators of pain, namely mucosal hypersensitivity, pelvic muscle floor dysfunction and general pain management. Treatment as usual, on the other hand, is primarily based on a sequential model applying one type of treatment at a time.

The investigator's aim is to compare multidisciplinary treatment including multimodal physiotherapy (intervention group) with standard treatment (control group) in reducing pain, sexual dysfunction and related symptoms in women with vulvodynia.

The study sample will be allocated randomly 1:1 to multidisciplinary treatment by a vulva team or to standard treatment by a specialist in gynaecology. The intervention will include a joint consultation by a gynaecologist and a dermatologist, tailored multimodal physiotherapy by a physiotherapist and guided imagery (mindfulness and relaxation) by use of a sound track during home sessions. The controls will receive standard care by a gynaecologist, who is free to offer any kind of non-standardized treatment.

Treatment effect will be measured at 3 months and at 6-12 months after inclusion. ;

Related Conditions & MeSH terms

• Chronic Pain
• Vulvodynia

• NCT number: NCT03640624
• Study type: Interventional
• Source: Norwegian University of Science and Technology
• Contact: Cecilie Therese Hagemann
• Phone: +47 97159869
• Email: cecilie.hagemann@ntnu.no
• Status: Recruiting
• Phase: N/A
• Start date: September 18, 2018
• Completion date: June 2024